Qian, Y., Tang, L., Yao, J., Zhu, Y., Zhang, Y., Lu, H., Li, W., An, C., Gui, L. (2025). Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic nasal cavity and paranasal sinus squamous-cell carcinoma: A prospective phase ll study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6022